ArticleFrontiers in immunology2022

Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration.

Julia Baguña Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.